A two-gene epigenetic signature for the prediction of response to neoadjuvant chemotherapy in triple-negative breast cancer patients

BACKGROUND: Pathological complete response (pCR) after neoadjuvant chemotherapy (NAC) in triple-negative breast cancer (TNBC) varies between 30 and 40% approximately. To provide further insight into the prediction of pCR, we evaluated the role of an epigenetic methylation-based signature. METHODS: E...

Descripción completa

Detalles Bibliográficos
Autores principales: Pineda, Begoña, Diaz-Lagares, Angel, Pérez-Fidalgo, José Alejandro, Burgués, Octavio, González-Barrallo, Inés, Crujeiras, Ana B., Sandoval, Juan, Esteller, Manel, Lluch, Ana, Eroles, Pilar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381754/
https://www.ncbi.nlm.nih.gov/pubmed/30786922
http://dx.doi.org/10.1186/s13148-019-0626-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381754/
https://www.ncbi.nlm.nih.gov/pubmed/30786922
http://dx.doi.org/10.1186/s13148-019-0626-0

Ejemplares similares